We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Updates Part 11 Guidance for Clinical Trials to Include Mobile and Wearable Tech
FDA Updates Part 11 Guidance for Clinical Trials to Include Mobile and Wearable Tech
The FDA has released a new draft guidance that clarifies the Part 11 regulations for electronic records and signatures as they apply to clinical trials, including validation of mobile and wearable technology and the use of outsourcing and contracting.